Heidenreich, Adrian
Stachon, Peter
Oettinger, Vera
Hilgendorf, Ingo
Heidt, Timo
Rilinger, Jonathan
Zehender, Manfred
Westermann, Dirk
von zur Mühlen, Constantin
Kaier, Klaus
Funding for this research was provided by:
DW received fees from Abiomebd, AstraZeneca, Bayer, Boehringer Ingelheim, Berlin-Chemie, Edwards Lifescience, Medtronic, and Novartis.
Universitätsklinikum Freiburg
Article History
Received: 13 August 2022
Accepted: 29 March 2023
First Online: 6 April 2023
Declarations
:
: Our study did not involve direct access by the investigators to data on individual patients but only access to summary results provided by the Research Data Centre. Therefore, approval by an ethics committee and informed consent were determined not to be required, in accordance with German law.
: Not applicable.
: DW received fees from Abiomebd, AstraZeneca, Bayer, Boehringer Ingelheim, Berlin-Chemie, Edwards Lifescience, Medtronic, and Novartis. ALL other authors have no competing interest.